Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-12

Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety, tolerability, and pharmacokinetics of oral mycophenolate mofetil (CellCept) in pediatric liver transplant recipients on cyclospo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pediatric Liver Transplantation | Phase 2 | Status: TERMINATED | Results posted: 2016-04-12